<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04696016</url>
  </required_header>
  <id_info>
    <org_study_id>P2020/402 / B4062020000124</org_study_id>
    <nct_id>NCT04696016</nct_id>
  </id_info>
  <brief_title>Guiding Sufentanil Administration With Skin Conductance in Mechanically Ventilated Intensive Care Patients</brief_title>
  <official_title>Guiding Sufentanil Administration With Skin Conductance in Mechanically Ventilated Intensive Care Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasme University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Opioid administration in mechanically ventilated patients in the intensive care unit (ICU) is&#xD;
      essential to maintaining patient respiratory and hemodynamic stability. Mechanical&#xD;
      ventilation is a persistently nociceptive event that can continuously causes discomfort in&#xD;
      the trachealy intubated patient. This can lead to patient-ventilator dyssynchrony,&#xD;
      tachycardia, hypertension, and their associated complications. Opioids blunt respiratory&#xD;
      drive, which facilitates mechanical ventilation, and decrease the sympathetic response to&#xD;
      nociception. However, excessive opiate administration is associated with many adverse events,&#xD;
      including respiratory depression, delirium, ileus, nausea, and vomiting. Currently, the&#xD;
      standard administration in our institution of sufentanil, a potent opiate, consists of&#xD;
      continuous infusions of 0.15µg/kg/h to 0.3µg/kg/h.&#xD;
&#xD;
      Mechanically ventilated patients are unable to speak and are often sedated. This greatly&#xD;
      impacts the patient's capacity to communicate pain. The use of a nociceptive monitor may be a&#xD;
      possible solution. Skin conductance monitoring (Pain Monitor, Med-Storm, Norway), measures&#xD;
      the peaks per second of electrical conduction. This non hemodynamic monitor uses skin&#xD;
      conduction as a surrogate to nociception (i.e., the patient's unconscious response to a&#xD;
      noxious stimulus). It may consequently guide opioid administration in ICU patients towards&#xD;
      and avoid the consequences of excessive or inadequate antinociception.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2021</start_date>
  <completion_date type="Anticipated">July 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concentration of sufentanil requirements</measure>
    <time_frame>one day to 2 weeks</time_frame>
    <description>Sufentanil requirements (µg/kg/h)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concentration of propofol requirements</measure>
    <time_frame>one day to 2 weeks</time_frame>
    <description>Propofol requirements (mg/kg/h)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of noradrenaline requirements (concentration of)</measure>
    <time_frame>one day to 2 weeks</time_frame>
    <description>noradrenaline requirements (µg/kg/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intubation time</measure>
    <time_frame>one day to 2 weeks</time_frame>
    <description>Total time of mechanical ventilation (intubated)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite post extubation related complications</measure>
    <time_frame>one day to 2 weeks</time_frame>
    <description>post extubation opioid related complications (e.g., delirium, vomiting, nausea, ileus, respiratory acidosis, hypoxemia, reintubation).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Nociceptive Pain</condition>
  <arm_group>
    <arm_group_label>Skin conductance guided</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sufentanil is titrated by the intensive care team to maintain skin conductance in target</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sufentanil is titrated at the discretion of the intensivist</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Skin conductance guided antinociception</intervention_name>
    <description>The value of skin conductance guides the titration of sufentanil</description>
    <arm_group_label>Skin conductance guided</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard care antinociception</intervention_name>
    <description>The intensive care team titrates antinociception based on their standard approach (using a clinical approach by assessing blood pressure, heart rate, and ventilator dyssynchrony).</description>
    <arm_group_label>Standard care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patient admitted to the ICU requiring endotracheal intubation, antinociception,&#xD;
             and sedation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Traumatic brain injury&#xD;
&#xD;
          -  use of ketamine, dexmedetomidine, or clonidine&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabio Taccone</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université Libre de Bruxelles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sean Coeckelenbergh</last_name>
    <phone>32 (0) 2 555 39 19</phone>
    <email>sean.coeckelenbergh@ulb.be</email>
  </overall_contact>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 4, 2021</study_first_submitted>
  <study_first_submitted_qc>January 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nociceptive Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

